InvestorsHub Logo
Followers 16
Posts 302
Boards Moderated 0
Alias Born 12/10/2014

Re: XenaLives post# 25918

Saturday, 03/14/2015 11:15:07 AM

Saturday, March 14, 2015 11:15:07 AM

Post# of 41703
Attached is a link about a 363 sale. It is essentially a liquidation sale of specific assets. The reference to Industrial Sapphire and specialty furnaces would in all probability include all associated IP. Specialty furnaces would include Silicon Carbide which might be of interest to Cree but they are making 6" + wafers and GT was at 4" I believe. Apple or Foxconn might be interested in the Sapphire IP but could do a "work around" most of it.
This probably includes selling off Thermal Technologies which was acquired in the last couple of years as their forte was specialty furnaces which included Merlin which GT will apparently retain.

If the BNCT is aimed at the medical arena that will be a tough. long slog as there is competition already in medical trials...Mevion for one. I am estimating 2 years to get to trials.

It is unlikely that GT will ever reach $1B in revenue again with a radically pared down offering. The Sapphire decision may be influenced by unresolved performance / liability issues...Tera Xtal still had not been paid its arbitration award the last time I checked. I believe there is a docket item.

http://www.law360.com/articles/465264/key-elements-of-the-section-363-sale-process

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.